-
Regulatory March 7, 2024Vivesto doses first patient in its clinical Paccal Vet trial
-
Non Regulatory January 30, 2024Vivesto’s international patent application for XR-18 receives positive decision
-
Non Regulatory December 28, 2023Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment
Year-end report 2023
Vivesto published its year-end report for 2023 on February 22, 2024, at 08.00 am CET.
The report was published in Swedish.